Capecitabine Pregnancy and Breastfeeding Warnings
Capecitabine is also known as: Xeloda
Capecitabine Pregnancy Warnings
Capecitabine has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of embryolethality, teratogenicity, and fetolethality. There are no controlled data in human pregnancy. If the drug is to be used during pregnancy or if the patient becomes pregnant while receiving this drug, the patient should be informed of the potential hazard to the fetus.
It is recommended that women of childbearing potential be advised to avoid becoming pregnant while receiving treatment with capecitabine. Animal studies on fertility and general reproductive performance have reported that doses of 760 mg/kg/day disturbed estrus and therefore caused a decrease in fertility. When pregnancy occurred, no fetus survived this dose. In male animals, a dose of 760 mg/kg/day caused degenerative changes in the testes, including decreases in the number of spermatocytes and spermatids.
Capecitabine Breastfeeding Warnings
There are no data on the excretion of capecitabine into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, it has been recommended that nursing be discontinued when a patient is receiving capecitabine therapy.
- capecitabine Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.